Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy.
The role of podocytes in the development and progression of glomerular disease has been extensively investigated in the past decade. However, the importance of glomerular endothelial cells in the pathogenesis of proteinuria and glomerulosclerosis has been largely ignored. Recent studies have demonstrated that endothelial nitric oxide synthatase (eNOS) deficiency exacerbates renal injury in anti-GBM and remnant kidney models and accelerates diabetic kidney damage. Increasing evidence also demonstrates the importance of the glomerular endothelium in preventing proteinuria. We hypothesize that endothelial dysfunction can initiate and promote the development and progression of glomerulopathy. Administration of adriamycin (ADR) to C57BL/6 mice, normally an ADR resistant strain, with an eNOS deficiency induced overt proteinuria, severe glomerulosclerosis, interstitial fibrosis and inflammation. We also examined glomerular endothelial cell and podocyte injury in ADR-induced nephropathy in Balb/c mice, an ADR susceptible strain, by immunostaining, TUNEL and Western blotting. Interestingly, down-regulation of eNOS and the appearance of apoptotic glomerular endothelial cells occurred as early as 24 hours after ADR injection, whilst synaptopodin, a functional podocyte marker, was reduced 7 days after ADR injection and coincided with a significant increase in the number of apoptotic podocytes. Furthermore, conditioned media from mouse microvascular endothelial cells over-expressing GFP-eNOS protected podocytes from TNF-α-induced loss of synaptopodin. In conclusion, our study demonstrated that endothelial dysfunction and damage precedes podocyte injury in ADR-induced nephropathy. Glomerular endothelial cells may protect podocytes from inflammatory insult. Understanding the role of glomerular endothelial dysfunction in the development of kidney disease will facilitate in the design of novel strategies to treat kidney disease.
Department of Anatomy and Developmental Biology, Monash University, Wellington Road, Clayton, Victoria, Australia.
Yu Bo Yang
YB
Sun
Xinli
X
Qu
Xueming
X
Zhang
Georgina
G
Caruana
John F
JF
Bertram
Jinhua
J
Li
D000818:Animals; D015153:Blotting, Western; D017077:Culture Media, Conditioned; D004317:Doxorubicin / Q000633:toxicity*; D004730:Endothelium, Vascular / Q000201:enzymology / Q000473:pathology*; D020287:In Situ Nick-End Labeling; D007668:Kidney / Q000187:drug effects*; D007678:Kidney Glomerulus / Q000473:pathology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D018613:Microscopy, Confocal; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism; D050199:Podocytes / Q000473:pathology*
D017077:Culture Media, Conditioned; D004317:Doxorubicin; D052250:Nitric Oxide Synthase Type III